Dismantling Silos: What is Next for Translational Research?
The journey from a brilliant scientific discovery to a life-saving clinical treatment is notoriously long, costly, and fragmented. Historically, the industry has treated "Discovery" and "Clinical Execution" as entirely separate islands. But as complex new therapeutic modalities emerge, this siloed approach is no longer sustainable.
Join us on Thursday, 2 July (10:00 AM – 5:15 PM) at ARC Oxford for the thirteenth Creative Disruption Forum (CDF). Hosted by strategic consultant Graham Combe and expertly moderated by resident thought-disruptor Prof. Tony Sedgwick, this full-day interactive forum brings together biotech founders, CXOs, R&D directors, and life science investors to fundamentally reshape how we translate science into medicine.
Why Attend?
Instead of enduring passive, slide-heavy lectures, you will participate in dynamic, unscripted morning keynote interviews followed by collaborative afternoon workshops. Under strict Chatham House Rules, attendees can engage in honest, authentic dialogue about the real barriers facing drug development today.
The agenda will explicitly dive into the dual pillars driving the next generation of translational research:
• Breaking the Discovery-Clinical Divide: Learn how forward-thinking biopharma companies are integrating clinical insights into early-stage discovery, ensuring that new assets are optimized for human trials from day one.
• The Power of New NAM Technologies: Get the latest insights into New Approach Methodologies (NAMs)—including advanced in vitro human models, organ-on-a-chip technologies, and high-throughput microphysiological systems—that are replacing traditional preclinical models and delivering highly predictive human data early.
• Breaking the Discovery-Clinical Divide: Discover how global regulatory bodies are reacting to NAMs and changing trial frameworks. We will discuss feedback on how to successfully validate these technologies to gain regulatory acceptance and safely accelerate candidate timelines.
Testimonial:
"So pleased to represent Sitryx at the fantastic #creativedisruption forum. As always, Tony Sedgwick challenged us to think about how we do #drugdiscovery and what opportunities we see in the future."
— Jon Ellery, Director of Biology, Sitryx
Event Details
Date & Time: Thursday, 2 July 2026 from 10 am
Venue: ARC Oxford, Garsington Road, Oxford, OX4 2SU
Format: In-person networking, live keynote interviews, and collaborative workshops (Lunch included)
Audience: Biotech & Biopharma Executives, CSOs, R&D Directors, Investors, Head of PreClinical, Translational Scientists, Aspiring Industry Leaders
Space is limited to preserve an intimate environment conducive to genuine peer-to-peer connection. Secure your pass today on Eventbrite and help shape the future framework of translational science.
